Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Banking
      • Tech
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • Abu Dhabi Finance Week
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Hercules
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Havas keeps quiet on whether Ian Osborne will stay on board after Epstein files

      Ian Osborne engaging online, showcasing digital interaction in a business setting with a focus on technology and communica...

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Super Bowl 2026: Where to watch in London this weekend

      General news article image with relevant context and details for business and news website readers

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • New Openings
      • Toast the City Awards
      • The Magazine
      • City Winners
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Super Bowl 2026: Where to watch in London this weekend

      General news article image with relevant context and details for business and news website readers

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • City AM Events
  • Newsletters
  • Latest Paper
  • Sign In
  • Sign Out
  • My Account

weight loss

  • Weight-loss drugs ‘fundamentally changing’ the way Brits eat

    Retail

    The rise of weight-loss drugs is starting to affect supermarket sales, with experts warning that the sector is unprepared for the change this Christmas. More than one in ten Brits is set to host someone on GLP-1 medication this year, prompting less alcohol and fewer sweets on the menu. “There is a worry that Christmas [...]

    Just under two thirds of households say they are concerned about the cost of their food shop
  • Mounjaro sales help almost double Ely Lilly’s UK turnover

    The sale of weight loss drug Mounjaro has boosted the UK turnover of pharmaceuticals giant Eli Lilly by 90 per cent during its latest financial year, it has been revealed. The division of the US group has posted a turnover of £889m for 2024, according to new accounts filed with Companies House. The new total [...]

    UK profit at Eli Lilly has also been boosted because of the sale of Mounjaro. (Photo by Scott Olson/Getty Images)
  • Mounjaro and Wegovy demand helps Chemist4U sales double

    healthcare

    Increasing demand for weight-loss jabs such as Mounjaro and Wegovy has helped sales at the firm behind online pharmacy Chemist4U almost double. The Skelmersdale-based business has reported a turnover of £59.5m for the year to 30 September, 2024, according to new accounts filed with Companies House. The latest total comes after the firm behind Chemist4U [...]

    Sales at the company behind Chemist4U have doubled thanks to the demand for weight-loss drugs. (Photo Illustration by Scott Olson/Getty Images)
  • Vitality to offer discounted weight loss drugs in UK first

    February 12, 2025

    Customers are to be offered discounted weight loss treatments through insurance giant Vitality in a UK first. The group, which is UK’s third-largest health insurer behind Bupa and Axa, is to offer discounts of up to 20 per cent for medications such as Wegovy and Mounjaro to its 1.9 million members. The offer is to [...]

  • Ozempic and Wegovy: What happens when a drug goes viral?

    May 18, 2024

    Novo Nordisk's Wegovy and Ozempic have been heralded as the solution to the world's growing obesity problems. But when celebrities and influencers misuse them and start documenting their weight loss journeys online, should we take stock?

Trending Articles

  • Red signal for £500m Central line upgrade after just four trains refitted

  • Bank of England Live: Interest rates held in narrow 5-4 call

  • Bank of England raises alarm on unemployment as interest rates unchanged 

  • Rolls-Royce: FTSE 100 giants shares eye all-time high in tariff comeback

  • Anthropic’s new AI legal tool wipes billions off European data stocks

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City AM Curated
  • The Punter
  • City Winners
  • Casino

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Tickets
Copyright 2026 City AM Limited